%D9%84%D9%8A%D9%81%D9%88%D9%81%D9%84%D9%88%D9%83%D8%B3%D8%A7%D8%B3%D9%8A%D9%86%D9%84%D9%88%D9%88%D9%81%D9%84%D9%88%DA%A9%D8%B3%D8%A7%D8%B3%DB%8C%D9%86%E0%A6%B2%E0%A6%BF%E0%A6%AD%E0%A7%8B%E0%A6%AB%E0%A7%8D%E0%A6%B2%E0%A6%95%E0%A7%8D%E0%A6%B8%E0%A6%BE%E0%A6%B8%E0%A6%BF%E0%A6%A8Category:LevofloxacinLefofflocsacinLevofloxacinLevofloxacinLevofloxacino%D9%84%D9%88%D9%88%D9%81%D9%84%D9%88%DA%A9%D8%B3%D8%A7%D8%B3%DB%8C%D9%86LevofloksasiiniL%C3%A9vofloxacineLevofloxacina%D7%9C%D7%91%D7%95%D7%A4%D7%9C%D7%95%D7%A7%D7%A1%D7%A6%D7%99%D7%9F%E0%A4%B2%E0%A4%BF%E0%A4%B5%E0%A5%8B%E0%A4%AB%E0%A4%BC%E0%A5%8D%E0%A4%B2%E0%A5%89%E0%A4%95%E0%A5%8D%E0%A4%B8%E0%A4%BE%E0%A4%B8%E0%A4%BF%E0%A4%A8%D4%BC%D6%87%D5%B8%D6%86%D5%AC%D6%85%D6%84%D5%BD%D5%A1%D6%81%D5%AB%D5%B6LevofloksasinLevofloxacina%E3%83%AC%E3%83%9C%E3%83%95%E3%83%AD%E3%82%AD%E3%82%B5%E3%82%B7%E3%83%B3%EB%A0%88%EB%B3%B4%ED%94%8C%EB%A1%9D%EC%82%AC%EC%8B%A0Levofloxacine%E0%AC%B2%E0%AD%87%E0%AC%AD%E0%AD%8B%E0%AC%AB%E0%AD%8D%E0%AC%B2%E0%AD%8B%E0%AC%95%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AC%BE%E0%AC%B8%E0%AC%BF%E0%AC%A8%E0%AD%8DLewofloksacynaLevofloxacinaLevofloxacin%C4%83%D0%9B%D0%B5%D0%B2%D0%BE%D1%84%D0%BB%D0%BE%D0%BA%D1%81%D0%B0%D1%86%D0%B8%D0%BDLevofloksacinLevofloksacinLevofloksacinLevofloxacin%E0%AE%B2%E0%AF%86%E0%AE%B5%E0%AF%8A%E0%AE%83%E0%AE%AA%E0%AF%8D%E0%AE%B2%E0%AF%8B%E0%AE%95%E0%AF%8D%E0%AE%9A%E0%AE%9A%E0%AE%BF%E0%AE%A9%E0%AF%8D%E0%B8%A5%E0%B8%B5%E0%B9%82%E0%B8%A7%E0%B8%9F%E0%B8%A5%E0%B8%AD%E0%B8%81%E0%B8%8B%E0%B8%B2%E0%B8%8B%E0%B8%B4%E0%B8%99%D0%9B%D0%B5%D0%B2%D0%BE%D1%84%D0%BB%D0%BE%D0%BA%D1%81%D0%B0%D1%86%D0%B8%D0%BDLevofloxacin%E5%B7%A6%E6%B0%A7%E6%B0%9F%E6%B2%99%E6%98%9FQ424193%E5%B7%A6%E6%B0%A7%E6%B0%9F%E6%B2%99%E6%98%9F
about
chlamydia infectionlegionnaires' diseasesinusitismaxillary sinusitispulmonary tuberculosisEscherichia coli infectious diseaseacute bronchitisgram-negative bacterial infectionurinary tract infectionupper respiratory tract infectionstaphylococcal infectionbacterial pneumoniapyelonephritischolesteatomaPseudomonas infection
P2176
P3364
P3781
Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis AgentsThe Effect of Colistin Inhalation on Ventilator Associated PneumoniaPopulation Pharmacokinetics of Anti-tuberculosis Drugs in Children With TuberculosisLevofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract InfectionsZinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological MalignanciesA Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial SinusitisA Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic BronchitisA Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult PatientsA Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in AdultsMDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary TuberculosisEffectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular SurgeryA Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory DiseaseCeftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal PneumoniaEnteroaggregative E.Coli (EAEC)A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)Trial of Antimycobacterial Therapy in SarcoidosisCeftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB)Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic FibrosisDoes Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is PresentEvaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract SurgeryLevo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract SurgeryTailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin AllergyEfficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori InfectionClinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract InfectionOptimizing the Antibiotic Treatment of Uncomplicated Acute AppendicitisAntibiotics vs. Placebo in Acute Uncomplicated AppendicitisA Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsEfficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter PyloriAn Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori InfectionPharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial PneumoniaPhase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line TherapyQuinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot StudyAsymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal TransplantsStudy Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including PyelonephritisTo Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) TreatmentPrevention of Oral Mucositis After Using Oral Topical Vitamin E Versus Voriconazole and Levofloxacin in Pediatric Cancer Patients Receiving Chemotherapy
P4844
Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.High rates of quinolone resistance among urinary tract infections in the ED.Aqueous chlorination of levofloxacin: kinetic and mechanistic study, transformation product identification and toxicity.In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniaeFluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrBAntimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in SpainPrevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide
P921
Q153356-C7E324E2-CA1A-4889-8A72-78B9DFD2EBAAQ154882-F5375EE6-AB60-4205-82AE-266E0504AFD3Q183344-7009C2B0-2345-48CC-BD85-BE0F8BA1647FQ18554971-B61DB9B6-F05A-469F-BEFE-4BE08730E0A5Q18555243-330B91E4-C35E-4A1D-99EC-2999FBD2C52AQ18975220-0FA222CF-9FA9-4E1C-916C-7958B5386F6BQ1900400-7F92ED62-E072-44C8-8508-1DE8A93F1306Q19597369-1F50AACF-D57D-47E2-9268-88791496C0C6Q221668-18E43B38-A1D7-45F3-BBE7-5D8B5F5F961AQ2622199-8ED449D1-B5CA-4273-9D6B-53A04822E168Q34879-D12C650D-28AE-4EFC-9862-33DF4441F767Q3776920-E6CFE342-E604-4D3A-8598-3AB48C865E9DQ506652-07D3E615-24F0-4812-9A5A-008EF2AA781FQ558230-985ba5c8-4eaa-3457-54b0-c237c50e0f83Q7255052-37517A43-6E7D-44D2-8B6D-8B77A1CF653E
P2176
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
L-ofloksacyna
@pl
Levofloksacin
@sh
Levofloksacin
@sl
Levofloksasiini
@fi
Levofloksasin
@id
Levofloxacin
@de
Levofloxacin
@sv
Levofloxacin
@ur
Levofloxacina
@gl
Levofloxacine
@nl
type
label
L-ofloksacyna
@pl
Levofloksacin
@sh
Levofloksacin
@sl
Levofloksasiini
@fi
Levofloksasin
@id
Levofloxacin
@de
Levofloxacin
@sv
Levofloxacin
@ur
Levofloxacina
@gl
Levofloxacine
@nl
altLabel
(-)-Ofloxacin
@cy
(-)-Ofloxacin
@en
(2S)-7-fluoro-2-methyl-6-(4-me ...... 11-tetraene-11-carboxylic acid
@cy
(2S)-7-fluoro-2-methyl-6-(4-me ...... 11-tetraene-11-carboxylic acid
@en
(3S)-(-)-9-Fluoro-3-methyl-10- ...... ]benzoxazine-6-carboxylic acid
@en
(3S)-(-)-9-fluoro-3-methyl-10- ...... ]benzoxazine-6-carboxylic acid
@en
(S)-(-)-9-Fluoro-3-methyl-10-( ...... benzooxazine-6-carboxylic acid
@en
(S)-(-)-9-fluoro-3-methyl-10-( ...... benzooxazine-6-carboxylic acid
@en
(S)-9-Fluoro-2,3-dihydro-3-met ...... -benzoxazine-6-carboxylic acid
@en
(S)-Ofloxacin
@en
prefLabel
L-ofloksacyna
@pl
Levofloksacin
@sh
Levofloksacin
@sl
Levofloksasiini
@fi
Levofloksasin
@id
Levofloxacin
@de
Levofloxacin
@sv
Levofloxacin
@ur
Levofloxacina
@gl
Levofloxacine
@nl